Daniel J. Lodge

The University of Texas Health Science Center at San Antonio, San Antonio, TX, United States 
Dopamine, Hippocamous, Neurophysiology, Schizophrenia, Drug Abuse
"Daniel Lodge"
Mean distance: 14.33 (cluster 40)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Elam HB, Perez SM, Donegan JJ, et al. (2021) Orexin receptor antagonists reverse aberrant dopamine neuron activity and related behaviors in a rodent model of stress-induced psychosis. Translational Psychiatry. 11: 114
Bugay V, McCoy AM, Lodge DJ, et al. (2020) Mechanisms associated with the antidepressant-like effects of L-655,708. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Donegan JJ, Boley AM, Glenn JP, et al. (2020) Developmental alterations in the transcriptome of three distinct rodent models of schizophrenia. Plos One. 15: e0232200
Carreno FR, Lodge DJ, Frazer A. (2020) Ketamine: Leading us into the future for development of antidepressants. Behavioural Brain Research. 383: 112532
Donegan JJ, Lodge DJ. (2020) Stem Cells for Improving the Treatment of Neurodevelopmental Disorders. Stem Cells and Development
Lodge D, Perez S. (2020) Targeting Upstream Pathways to Reverse Aberrant Dopamine System Function Biological Psychiatry. 87
Donegan JJ, Boley AM, Yamaguchi J, et al. (2019) Modulation of extrasynaptic GABA alpha 5 receptors in the ventral hippocampus normalizes physiological and behavioral deficits in a circuit specific manner. Nature Communications. 10: 2819
Perez SM, Donegan JJ, Lodge DJ. (2019) Effect of estrous cycle on schizophrenia-like behaviors in MAM exposed rats. Behavioural Brain Research
Lodge D, Donegan J. (2019) 40.1 Targeting Hippocampal Interneuron Function As A Therapeutic Approach For Schizophrenia Schizophrenia Bulletin. 45
Perez SM, Donegan JJ, Boley AM, et al. (2018) Ventral hippocampal overexpression of Cannabinoid Receptor Interacting Protein 1 (CNRIP1) produces a schizophrenia-like phenotype in the rat. Schizophrenia Research
See more...